Venecuēla - spāņu - Instituto Nacional de Higiene

laboratorio eicopen c.a. - emtricitabina -rilpivirina-tenofovir - tabletas recubiertas - 200 mg - 27,5 mg - 3

Venecuēla - spāņu - Instituto Nacional de Higiene

productos roche, s.a. - oseltamivir - capsulas - 75 mg

Eiropas Savienība - spāņu - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agentes antineoplásicos - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Peru - spāņu - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

logistics business services s.a.c. - droguerÍa - comprimido recubierto - por comprimido - - sofosbuvir y velpatasvir

Venecuēla - spāņu - Instituto Nacional de Higiene

laboratorio eicopen c.a. - ledipasvir - sofosbuvir - comprimidos recubiertos - 90 mg - 400 mg

Venecuēla - spāņu - Instituto Nacional de Higiene

laboratorio eicopen c.a. - sofosbuvir - tabletas recubiertas - 400 mg

Eiropas Savienība - spāņu - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - linfoma, célula del manto - agentes antineoplásicos - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Peru - spāņu - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

logistics business services s.a.c. - droguerÍa - tableta recubierta - por vial - - tenofovir disoproxiol y emtricitabina

Čīle - spāņu - ISPC (Instituto de Salud Pública de Chile)

pharmaris chile s.p.a. - dolutegravir; lamivudina; tenofovir disoproxil fumarato - sin formulas

Čīle - spāņu - ISPC (Instituto de Salud Pública de Chile)

gador ltda. - bictegravir; emtricitabina; tenofovir alafenamida fumarato - sin formulas